IMMUNOPROPHYLAXIS IN THE TREATMENT OF HIV-INFECTED PATIENTS IN BRONCHOPULMONARY PATHOLOGY

Abstract

HIV-infection is a widespread and social importance disease. HIV-infection leads to secondary immunodeficiency and lower resistance to infectious diseases, such as influenza and pneumo coccal infection. In this regard, the relevant vaccination against pneumococcal infection and influenza in the risk group. According to research, 91% HIV-infected respond to the 23-valent pneumococcal polysaccharide vaccine (PKV23), and duration of immunity is 5 and more years. Vaccination against influenza had effect in 76% patients, it was lower, than in health control. This data suggests, that new vaccines and immunization scheme are needed.

Keywords

• hiv-infection
• pneumococcal infection
• influenza
• bronchopulmonary pathology
• vaccination